Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Pipeline report flags continued pressure The insurer's annual outlook, aimed at private plan sponsors, lists GLP-1 therapies among the leading themes of 2026 and warns that ongoing launches of newer, more expensive drugs are putting increased financial pressure on private drug plans [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php]
Performance Recovery IV Therapy is specially formulated to replenish vital nutrients, electrolytes, and antioxidants lost during intense physical activity, sports training, or weightlifting sessions
5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia
C.JacksonV
Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle
Fleury D, Jefferies S, Kuchel H, Langridge P
US$ 23.82
US$ 27.44
US$ 23.80
US$ 21.76
US$ 27.57
US$ 27.04
US$ 29.56
US$ 20.80
US$ 25.52
US$ 23.93
